CIK 0001129928 · Non-accelerated filer<br>Smaller reporting company
ONCOLYTICS BIOTECH INC
Sign in to watch- Ticker
- ONCY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 980541667
- Phone
- 4036707377
- Business address
- SUITE 325, 4350 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-01 | McAdory John Bearden Chief Operating Officer | Grant or award · Stock Option | +145,000 | 145,000 | ||
| 2026-06-01 | Glover Stephen C. Director | Grant or award · Stock Option | +96,000 | 96,000 | ||
| 2026-06-01 | Brown Deborah Margaret Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2026-06-01 | RIGBY JONATHAN Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2026-06-01 | Pisano Wayne Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2026-06-01 | Holtham Angela Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2026-06-01 | Look Kirk Chief Financial Officer | Grant or award · Stock Option | +260,000 | 260,000 | ||
| 2026-06-01 | Parsons James T. Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2026-06-01 | Aromando Andrew Chief Business Officer | Grant or award · Stock Option | +260,000 | 260,000 | ||
| 2026-06-01 | Kelly Jared Chief Executive Officer | Grant or award · Stock Option | +755,000 | 755,000 | ||
| 2026-06-01 | Andrews Patricia S Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2026-06-01 | Seizinger Bernd R. Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2026-06-01 | Hagerman Allison Chief Technology Officer | Grant or award · Stock Option | +260,000 | 260,000 | ||
| 2026-06-01 | Heineman Thomas Charles Chief Medical Officer | Grant or award · Stock Option | +260,000 | 260,000 | ||
| 2026-03-12 | Kelly Jared Chief Executive Officer | Purchase | +5,050 | $0.96 | $5K | 114,050 |
| 2026-03-11 | Parsons James T. Director | Purchase | +10,000 | $1.03 | $10K | 41,849 |
| 2026-02-12 | Seizinger Bernd R. Director | Purchase | +40,000 | $0.85 | $34K | 566,991 |
| 2026-02-12 | Pisano Wayne Director | Purchase | +30,000 | $0.84 | $25K | 492,414 |
| 2026-02-12 | Look Kirk Chief Financial Officer | Purchase | +12,000 | $0.84 | $10K | 287,515 |
| 2026-02-12 | Kelly Jared Chief Executive Officer | Purchase | +29,500 | $0.84 | $25K | 109,000 |
Page 1 of 2 · 28 trades